Prevention of surgical site infection after oral cancer surgery by topical tetracycline: Results of a multicenter randomized control trial
- PMID: 29310375
- PMCID: PMC5728776
- DOI: 10.1097/MD.0000000000008891
Prevention of surgical site infection after oral cancer surgery by topical tetracycline: Results of a multicenter randomized control trial
Abstract
Background: In a pilot study, we showed that topical administration of a tetracycline could decrease oral bacteria levels for 6 hours in patients who underwent oral cancer surgery combined with tracheotomy and flap reconstruction. This multicenter, randomized control trial aimed to investigate the effectiveness of topical application of tetracycline ointment for prevention of surgical site infection (SSI) associated with major oral cancer surgery.
Methods: One hundred seventeen patients who underwent oral cancer resection combined with neck dissection, flap reconstruction, and tracheotomy were divided randomly into an intervention group (n = 56) and a control group (n = 61). The intervention consisted of topical administration of tetracycline ointment on the dorsum of the tongue every 6 hours for 48 hours postoperatively. Factors relating to the occurrence of SSI in both groups were subjected to logistic regression analysis.
Results: SSI occurred in 11 patients (19.6%) in the intervention group and 22 patients (36.1%) in the control group. Multivariate analysis showed that a longer operating time and not receiving topical tetracycline were independent risk factors for development of SSI.
Conclusion: Administration of topical tetracycline for 48 hours postoperatively is an effective way of preventing SSI after oral cancer surgery.
Conflict of interest statement
The authors report no conflicts of interest.
Figures
References
-
- Cunha TF, Melancia TA, Ribeiro CM, et al. Risk factors for surgical site infection in cervico-facial oncological surgery. J Craniomaxillofac Surg 2012;40:443–8. - PubMed
-
- Lee DH, Kim SY, Nam SY, et al. Risk factors of surgical site infection in patients undergoing major oncological surgery for head and neck cancer. Oral Oncol 2011;47:528–31. - PubMed
-
- Karakida K, Aoki T, Ota Y, et al. Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with microvascular free-flap reconstructions at a single university hospital. J Infect Chemother 2010;16:334–9. - PubMed
-
- Ogihara H, Takeuchi K, Majima Y. Risk factors of postoperative infection in head and neck surgery. Auris Nasus Larynx 2009;36:457–60. - PubMed
-
- Lotfi CJ, Cavalcanti RC, Costa e Silva AM, et al. Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg 2008;138:74–80. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
